))
Access For All: Adding MS DMTs to the WHO Essential Medicines List
Manage episode 407345650 series 3559522
Contenu fourni par European Committee for Treatment and Research in Multiple Sclerosis, The European Committee for Treatment, and Research in Multiple Sclerosis. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par European Committee for Treatment and Research in Multiple Sclerosis, The European Committee for Treatment, and Research in Multiple Sclerosis ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Everyone with MS should have access to the treatment and care that they need. Yet in 70% of countries, people face huge challenges in accessing disease modifying therapies (DMTs). Nick Rijke with the MS International Federation and Deanna Saylor of Johns Hopkins Hospital discuss a recent bid to add MS DMTs to the WHO's Essential Medicines List.
40 episodes
Partager
